Publikationen in Zusammenarbeit mit Forschern von Universidade de Santiago de Compostela (14)

1999

  1. Salivary gland is capable of GH synthesis under GHRH stimulation

    Journal of Endocrinology, Vol. 160, Núm. 2, pp. 217-222

1995

  1. Regulation of hypothalamic somatostatin by glucocorticoids

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 53, Núm. 1-6, pp. 277-282

1993

  1. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin

    Neuroendocrinology, Vol. 57, Núm. 6, pp. 1155-1160

  2. Glucocorticoids may inhibit growth hormone release by enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 439-444

1992

  1. Neuroendocrine control of growth hormone secretion in humans

    Trends in Endocrinology and Metabolism

1991

  1. Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man

    Clinical Endocrinology, Vol. 35, Núm. 2, pp. 129-135

  2. Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 73, Núm. 2, pp. 251-256

  3. Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: Studies with metoclopramide

    Neuroendocrinology, Vol. 53, Núm. 2, pp. 143-149

1990

  1. New concepts in the neuroregulation of growth hormone secretion

    Arquivos de Medicina, Vol. 3, Núm. 4, pp. 329-338

  2. α2-adrenergic agonism enhances the growth hormone (gh) response to gh-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 71, Núm. 6, pp. 1581-1588

1989

  1. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?

    Neuroendocrinology, Vol. 49, Núm. 5, pp. 551-554

  2. Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade

    Acta Endocrinologica, Vol. 120, Núm. 1, pp. 31-36

  3. REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC‐SOMATOTROPH RHYTHM (HSR)

    Clinical Endocrinology, Vol. 30, Núm. 4, pp. 367-377

1987

  1. GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE‐RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN‐PRETREATED VOLUNTEERS

    Clinical Endocrinology, Vol. 27, Núm. 5, pp. 517-523